Agenus (AGEN) Shares Outstanding (2010 - 2026)
Agenus (AGEN) posted quarterly Shares Outstanding (Entity) of $38.5 million for Q1 2026, up 45.02% year-over-year from $26.6 million in Q1 2025, and up 9.07% quarter-over-quarter from $35.3 million in Q4 2025.
Analysis
Agenus (AGEN) Shares Outstanding (2010 - 2026) Analysis & Trends
Agenus' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $38.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 45.02% year-over-year to $38.5 million; the TTM figure through Mar 2026 stood at $38.5 million (up 45.02% YoY), while the FY2025 annual figure was $35.3 million, up 49.44% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $38.5 million, up from $35.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $38.5 million in Q1 2026, with the low at $13337.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $21.0 million (2024), against an average of $14.8 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) slumped 99.87% in 2022, then surged 132312.49% in 2024.
- Agenus' Shares Outstanding (Entity) stood at $14087.0 in 2022, then advanced by 27.02% to $17894.0 in 2023, then soared by 131983.38% to $23.6 million in 2024, then surged by 49.44% to $35.3 million in 2025, then gained by 9.07% to $38.5 million in 2026.
- Business Quant data shows AGEN's Shares Outstanding (Entity) at $38.5 million in Q1 2026, $35.3 million in Q4 2025, and $32.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Agenus | 343.02 Mn | 343.02 Mn | 34.52 Mn | 41.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.34 Mn |
| Mar 31, 2026 | 37.94 Mn |
| Dec 31, 2025 | 29.73 Mn |
| Sep 30, 2025 | 31.89 Mn |
| Jun 30, 2025 | 28.12 Mn |
| Mar 31, 2025 | 24.47 Mn |
| Dec 31, 2024 | 21.47 Mn |
| Sep 30, 2024 | 21.55 Mn |
| Jun 30, 2024 | 21.06 Mn |
| Mar 31, 2024 | 20.37 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | 18.91 Mn |
| Jun 30, 2023 | 17.57 Mn |
| Mar 31, 2023 | 15.86 Mn |
| Dec 31, 2022 | 14.09 Mn |
| Sep 30, 2022 | 14.34 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 12.92 Mn |
| Dec 31, 2021 | 11.45 Mn |
| Sep 30, 2021 | 11.77 Mn |